BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18448553)

  • 1. Chemotherapy in elderly patients with colorectal cancer.
    Köhne CH; Folprecht G; Goldberg RM; Mitry E; Rougier P
    Oncologist; 2008 Apr; 13(4):390-402. PubMed ID: 18448553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemotherapy of elderly patients with colorectal cancer].
    Landherr L; Nagykálnai T
    Magy Onkol; 2009 Jun; 53(2):97-105. PubMed ID: 19581175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy of metastatic colorectal cancer.
    Prescrire Int; 2010 Oct; 19(109):219-24. PubMed ID: 21180382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recent results of irinotecan therapy in colorectal cancer].
    Láng I; Hitre E
    Magy Onkol; 2004; 48(4):281-8. PubMed ID: 15655572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current therapies for advanced colorectal cancer.
    Aggarwal S; Chu E
    Oncology (Williston Park); 2005 Apr; 19(5):589-95. PubMed ID: 15945340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes in elderly patients with advanced colorectal cancer treated with capecitabine: a population-based analysis.
    Ho C; Ng K; O'Reilly S; Gill S
    Clin Colorectal Cancer; 2005 Nov; 5(4):279-82. PubMed ID: 16356306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of new agents in the treatment of colorectal cancer.
    Folprecht G; Köhne CH
    Oncology; 2004; 66(1):1-17. PubMed ID: 15031593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of advanced colorectal cancer in the elderly.
    Bruce C; Köhne CH; Audisio RA
    Eur J Surg Oncol; 2007 Dec; 33 Suppl 2():S84-7. PubMed ID: 18006266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cetuximab plus XELIRI or XELOX for first-line therapy of metastatic colorectal cancer.
    Moosmann N; Heinemann V
    Clin Colorectal Cancer; 2008 Mar; 7(2):110-7. PubMed ID: 18501070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
    Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic therapy for colorectal cancer.
    Meyerhardt JA; Mayer RJ
    N Engl J Med; 2005 Feb; 352(5):476-87. PubMed ID: 15689586
    [No Abstract]   [Full Text] [Related]  

  • 12. Current status of capecitabine in the treatment of colorectal cancer.
    Rothenberg ML
    Oncology (Williston Park); 2002 Dec; 16(12 Suppl No 14):16-22. PubMed ID: 12520635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Insight: Metastatic colorectal cancer--oral fluoropyrimidines and new perspectives in the adjuvant setting.
    Folprecht G; Köhne CH
    Nat Clin Pract Oncol; 2005 Nov; 2(11):578-87. PubMed ID: 16270098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy, which drugs and when.
    Koopman M; Punt CJ
    Eur J Cancer; 2009 Sep; 45 Suppl 1():50-6. PubMed ID: 19775604
    [No Abstract]   [Full Text] [Related]  

  • 15. Physical function and quality of life in frail and/or elderly patients with metastatic colorectal cancer treated with capecitabine and bevacizumab: an exploratory analysis.
    Ward P; Hecht JR; Wang HJ; Dichmann R; Liem AK; Chan D; Patel R; Hu EH; Tchekmedyian NS; Wainberg ZA; Naeim A
    J Geriatr Oncol; 2014 Oct; 5(4):368-75. PubMed ID: 25002322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elderly patients with advanced colorectal cancer derive similar benefit without excessive toxicity after first-line chemotherapy with oxaliplatin-based combinations: comparative outcomes from the 03-TTD-01 phase III study.
    Sastre J; Aranda E; Massutí B; Tabernero J; Chaves M; Abad A; Carrato A; Reina JJ; Queralt B; Gómez-España A; González-Flores E; Rivera F; Losa F; García T; Sanchez-Rovira P; Maestu I; Díaz-Rubio E
    Crit Rev Oncol Hematol; 2009 May; 70(2):134-44. PubMed ID: 19111473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-based update of chemotherapy options for metastatic colorectal cancer.
    Damjanovic D; Thompson P; Findlay MP
    ANZ J Surg; 2004 Sep; 74(9):781-7. PubMed ID: 15379811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of treatment with chemotherapy and monoclonal antibodies for metastatic colorectal cancer in Western Europe.
    Zhao Z; Pelletier E; Barber B; Bhosle M; Wang S; Gao S; Klingman D
    Curr Med Res Opin; 2012 Feb; 28(2):221-9. PubMed ID: 22171947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cetuximab strongly enhances immune cell infiltration into liver metastatic sites in colorectal cancer.
    Inoue Y; Hazama S; Suzuki N; Tokumitsu Y; Kanekiyo S; Tomochika S; Tsunedomi R; Tokuhisa Y; Iida M; Sakamoto K; Takeda S; Ueno T; Yoshino S; Nagano H
    Cancer Sci; 2017 Mar; 108(3):455-460. PubMed ID: 28075526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of age on first-line systemic therapy in patients with metachronous metastases from colorectal cancer.
    Razenberg LG; van Erning FN; Pruijt HF; Ten Tije AJ; van Riel JM; Creemers GJ; Lemmens VE
    J Geriatr Oncol; 2017 Jan; 8(1):37-43. PubMed ID: 27659548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.